Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR2 | P50052 | 11/20 | 0.71 |
| ▸ | AGTR1 | P30556 | 10/20 | 0.71 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.71 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.71 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.71 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.71 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Olmesartan Medoxomil SCHEMBL96150 | 0.94 | AGTR2 (0.79) | AGTR2AGTR1ABCC3ABCC4ABCB11 | |
| SCHEMBL7886557 | 0.94 | AGTR2 (0.68) | AGTR2AGTR1ABCC3ABCC4ABCB11 | |
| SCHEMBL7883447 | 0.94 | AGTR2 (0.68) | AGTR2AGTR1ABCC3ABCC4ABCB11 | |
| SCHEMBL2844872 | 0.93 | AGTR2 (0.73) | AGTR2AGTR1ABCC3ABCC4ABCB11 | |
| SCHEMBL8243357 | 0.92 | AGTR2 (0.65) | AGTR2AGTR1ABCC3ABCC4ABCB11 | |
| SCHEMBL18744755 | 0.91 | AGTR2 (0.64) | AGTR2AGTR1ABCC3ABCC4ABCB11 | |
| SCHEMBL7886423 | 0.90 | AGTR2 (0.63) | AGTR2AGTR1ABCC3ABCC4ABCB11 | |
| SCHEMBL15132375 | 0.90 | AGTR2 (0.72) | AGTR2AGTR1ABCC3ABCC4ABCB11 | |
| SCHEMBL7444198 | 0.90 | AGTR2 (0.56) | AGTR2AGTR1ABCC3ABCC4ABCB11 | |
| SCHEMBL6857515 | 0.89 | AGTR2 (0.71) | AGTR2AGTR1ABCC3ABCC4ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0503785-B1 | 1-Biphenylimidazole derivatives, their preparation and their therapeutic use | SANKYO CO (JP) | 2001-04-25 | — | — | EP | claimed |
| US-5616599-A | HYPOTENSIVE AGENTS FOR CARDIOVASCULAR DISORDER | SANKYO COMPANY, LIMITED (JP) | 1997-04-01 | — | — | US | claimed |
| EP-0503785-A1 | 1-Biphenylimidazole derivatives, their preparation and their therapeutic use | Sankyo Company Limited (JP) | 1992-09-16 | — | — | EP | claimed |
| WO-2008149155-A1 | CRYSTALLINE FORM B OF OLMESARTAN MEDOXOMIL | GENERICS [UK] LIMITED (GB) | 2008-12-11 | — | — | WO | disclosed |
| EP-0503785-B1 | 1-Biphenylimidazole derivatives, their preparation and their therapeutic use | SANKYO CO (JP) | 2001-04-25 | — | — | EP | disclosed |
| US-5646171-A | HYPOTENSIVE AGENTS | SANKYO COMPANY, LIMITED (JP) | 1997-07-08 | — | — | US | disclosed |
| US-5616599-A | HYPOTENSIVE AGENTS FOR CARDIOVASCULAR DISORDER | SANKYO COMPANY, LIMITED (JP) | 1997-04-01 | — | — | US | disclosed |
| EP-0503785-A1 | 1-Biphenylimidazole derivatives, their preparation and their therapeutic use | Sankyo Company Limited (JP) | 1992-09-16 | — | — | EP | disclosed |